Early Changes in eDiary COPD Symptoms Predict Clinically Relevant Treatment Response at 12 Weeks: Analysis from the CRYSTAL Study

References

• Global Initiative for Chronic Obstructive Lung Disease. Global strategy for diagnosis, management and prevention of COPD; 2017 [cited 2017 Nov 29]. Available from www.goldcopd.org.
   Google Scholar
• van Buul AR, Kasteleyn MJ, Chavannes NH, Taube C. Association between morning symptoms and physical activity in COPD: a systematic review. Eur Respir Rev. 2017;26(143):160118. doi:10.1183/16000617.0033-2016. PMID: 28049129
   PubMed Web of Science ®Google Scholar
• Jones PW, Price D, van der Molen T. Role of clinical questionnaires in optimizing everyday care of chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2011;6:289–296. doi:10.2147/COPD.S18181. PMID: 21697993
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Ferrer J, Baro E, Lleonart M, Galera J. Differences between physician and patient in the perception of symptoms and their severity in COPD. Respir Med. 2013;107(12):1977–1985. doi:10.1016/j.rmed.2013.06.019. PMID: 23890959
   PubMed Web of Science ®Google Scholar
• Kuyucu T, Guclu SZ, Saylan B, Demir C, Senol T, Guner S, Koyuncu E, Ozen F, Oztürk S, Cangül Z. A cross-sectional observational study to investigate daily symptom variability, effects of symptom on morning activities and therapeutic expectations of patients and physicians in COPD-SUNRISE study. Tuberk Toraks. 2011;59(4):328–339. doi:10.5578/tt.3268. PMID: 22233302
   PubMedGoogle Scholar
• Jones PW, Quirk FH, Baveystock CM. The St George's Respiratory Questionnaire. Respir Med. 1991;85 (Suppl B):25–31; discussion 3–7. doi:10.1016/S0954-6111(06)80166-6. PMID: 1759018
   PubMed Web of Science ®Google Scholar
• Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. The American review of respiratory disease. 1992;145(6):1321–1327. doi:10.1164/ajrccm/145.6.1321. PMID: 1595997
   PubMed Web of Science ®Google Scholar
• van der Molen T, Willemse BW, Schokker S, ten Hacken NH, Postma DS, Juniper EF. Development, validity and responsiveness of the Clinical COPD Questionnaire. Health Qual Life Outcomes. 2003;1:13. doi:10.1186/1477-7525-1-13. PMID: 12773199
   PubMedGoogle Scholar
• Jones PW. COPD assessment test –rationale, development, validation and performance. COPD. 2013;10(2):269–271. doi:10.3109/15412555.2013.776920. PMID: 23547637
   PubMedGoogle Scholar
• Jones PW, Harding G, Berry P, Wiklund I, Chen WH, Kline Leidy N. Development and first validation of the COPD Assessment Test. Eur Respir J. 2009;34(3):648–654. doi:10.1183/09031936.00102509. PMID: 19720809
   PubMed Web of Science ®Google Scholar
• Leidy NK, Sexton CC, Jones PW, Notte SM, Monz BU, Nelsen L, Goldman M, Murray LT, Sethi S. Thorax. Measuring respiratory symptoms in clinical trials of COPD: reliability and validity of a daily diary. Thorax. 2014;69(5):443–449. doi:10.1136/thoraxjnl-2013-204428. PMID: 24595666
   PubMed Web of Science ®Google Scholar
• Health USDo, Human Services FDACfDE, Research, Health USDo, Human Services FDACfBE, Research, et al. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health Qual Life Outcomes. 2006;4:79. doi:10.1186/1477-7525-4-79. PMID: 17034633
   PubMed Web of Science ®Google Scholar
• Kulich K, Keininger DL, Tiplady B, Banerji D. Symptoms and impact of COPD assessed by an electronic diary in patients with moderate-to-severe COPD: psychometric results from the SHINE study. Int J Chron Obstruct Pulmon Dis. 2015;10:79–94. PMID: 25609942
   PubMed Web of Science ®Google Scholar
• Burgel PR, Le Gros V, Decuypere L, Bourdeix I, Perez T, Deslee G. Immediate salbutamol responsiveness does not predict long-term benefits of indacaterol in patients with chronic obstructive pulmonary disease. BMC Pulm Med. 2017;17(1):25. doi:10.1186/s12890-017-0372-z. PMID: 28143447
   PubMedGoogle Scholar
• Calverley PM, Postma DS, Anzueto AR, Make BJ, Eriksson G, Peterson S, Jenkins CR. Early response to inhaled bronchodilators and corticosteroids as a predictor of 12-month treatment responder status and COPD exacerbations. Int J Chron Obstruct Pulmon Dis. 2016;11:381–390. doi:10.2147/COPD.S93303.eCollection 2016. PMID: 26952309
   PubMed Web of Science ®Google Scholar
• Vogelmeier CF, Gaga M, Aalamian-Mattheis M, Greulich T, Marin JM, Castellani W, Ninane V, Lane S, Nunez X, Patalano F. Efficacy and safety of direct switch to indacaterol/glycopyrronium in patients with moderate COPD: the CRYSTAL open-label randomised trial. Respir Res. 2017;18(1):140. doi:10.1186/s12931-017-0622-x. PMID: 28720132
   PubMed Web of Science ®Google Scholar
• Donohue JF, Jones P, Bartels C, Marvel J, D'Andrea P, Banerji D, Donald B, Francesco P, Robert F. Relationship between change in trough FEV1 and COPD patient outcomes: Pooled analysis of 23 clinical trials in patients with COPD. Eur Respir J. 2015;46:PA1013. doi:10.1183/13993003.congress-2015.PA1013
   Web of Science ®Google Scholar
• Westwood M, Bourbeau J, Jones PW, Cerulli A, Capkun-Niggli G, Worthy G. Relationship between FEV1 change and patient-reported outcomes in randomised trials of inhaled bronchodilators for stable COPD: a systematic review. Respir Res. 2011;12:40. doi:10.1186/1465-9921-12-40. PMID: 21477298
   PubMed Web of Science ®Google Scholar
• Esteban C, Quintana JM, Aburto M, Moraza J, Capelastegui A. A simple score for assessing stable chronic obstructive pulmonary disease. QJM. 2006;99(11):751–759. doi:10.1093/qjmed/hcl110. PMID: 17030529
   PubMed Web of Science ®Google Scholar
• Rabe KF. Improving dyspnea in chronic obstructive pulmonary disease: optimal treatment strategies. Proc Am Thorac Soc. 2006;3(3):270–275. doi:10.1513/pats.200601-002SF. PMID: 16636097
   PubMedGoogle Scholar
• Powrie DJ, Wilkinson TM, Donaldson GC, Jones P, Scrine K, Viel K, Kesten S, Wedzicha JA. Effect of tiotropium on sputum and serum inflammatory markers and exacerbations in COPD. Eur Respir J. 2007;30(3):472–478. doi:10.1183/09031936.00023907. PMID: 17504798
   PubMed Web of Science ®Google Scholar
• McNicholas WT, Calverley PM, Lee A, Edwards JC. Long-acting inhaled anticholinergic therapy improves sleeping oxygen saturation in COPD. Eur Respir J. 2004;23(6):825–831. doi:10.1183/09031936.04.00085804. PMID: 15218993
   PubMed Web of Science ®Google Scholar
• Arnold SV, Kosiborod M, Li Y, Jones PG, Yue P, Belardinelli L, Spertus JA. Comparison of the Seattle Angina Questionnaire With Daily Angina Diary in the TERISA Clinical Trial. Circ Cardiovasc Qual Outcomes. 2014;7(6):844–850. doi:10.1161/CIRCOUTCOMES.113.000752. PMID: 25249560
   PubMed Web of Science ®Google Scholar
• Bastyr EJ, 3rd, Zhang S, Mou J, Hackett AP, Raymond SA, Chang AM. Performance of an electronic diary system for intensive insulin management in global diabetes Clinical Trials. Diabetes Technol Ther. 2015;17(8):571–579. doi:10.1089/dia.2014.0407. PMID: 25826466
   PubMed Web of Science ®Google Scholar